Japan Endovascular Treatment Conference 2014 JET2014 Digital Poster.

Slides:

Advertisements

Similar presentations

AAST 35 th ANNIVERSARY MEETING June 2-4, 2013 Hilton Baltimore Hotel Baltimore, Maryland Case Example Presenter: Case Example Title:

Advertisements

Japan Endovascular Treatment Conference 2015 JET2015 General Presentation.

Japan Endovascular Treatment Conference 2014 JET2014 コメディカルセッション.

DISCLOSURE STATEMENT Speaker: INSERT NAME Affiliation / Financial Interest Organization [TYPE] [NAMES OF COMPANIES] PAS Annual Meetings, May 2-5, 2009,

Japan Society for Hematopoietic Cell Transplantation COI disclosure Name of first author ： e.g., John Doe I have no personal or financial interests to.

Speaker Disclosure Explanation

Japan Endovascular Treatment Conference 2016 JET2016 General Presentation.

Financial Disclosures Financial interests, arrangements or affiliations that could be perceived as a real or apparent “conflict of interest” in the context.

COI Disclosure Information Example 2-1 Lead Presenter: Jane Doe Responsible Researcher: Jane Smith We have no financial relationships to disclose.

Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.

Speaker Name: Disclosure of Relevant Financial Relationships

Please use the sample slide format to disclose COI status

[Sample statement for poster presentations]

, when no conflicts of interest to disclose exist

We have no conflict of interests related to

for Respiratory Care and Rehabilitation

COI Disclosure of First Author

Faculty Disclosure Off-Label Product Use

Please use the sample slide format to disclose COI status

A Sample Slide Format to disclose your COI Status

The Japanese Society of Hematology COI Disclosure Name of Authors

COI Disclosure of First Author

Relevant Financial Disclosure(s)

　*Please use this slide template when there is no

Conflict of Interest Disclosure

Conflict of Interest Shilene Johnson- Research Compliance Specialist

Disclosure Information 87th Annual Scientific Meeting Speaker’s Name Here I have the following financial relationships to disclose: (select those that.

Significant (greater than $10K)

Faculty Disclosure Off-Label Product Use

The Japanese Circulation Society COI Disclosure Name of Authors :

Conflict of Interest Disclosure:

Disclosure Information 89th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Disclosure Information AACPDM 72nd Annual Meeting | October 9-13, 2018

FINANCIAL DISCLOSURES

Disclosure of conflicts of interest – explanation

If yes, give company names.

COI Disclosure All authors Name : （◎ Corresponding author）

Speaker Name: Disclosure of Relevant Financial Relationships

Conflict of interest disclosure

COI Disclosure STRUCTURE CLUB JAPAN Name of First Author

Disclosures The project was funded from the following sources:

Financial Disclosure Financial Interest / Affiliation

Faculty Disclosure Off-Label Product Use

Disclosures Relevant financial relationships in the past twelve months by presenter or spouse/partner. Employment: Company Name(s) Speakers Bureau:

Title of Talk Speaker name.

, when no conflicts of interest to disclose exist

Use the following slide to disclose any conflicts of interest

Disclosure Information 90th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.

Disclosure of conflicts of interest

Speaker Name: Disclosure of Relevant Financial Relationships

We have no conflict of interests related to

COI Disclosure Name of Lead Presenter:○○○○

Disclosure of conflicts of interest

Conflict of Interest Disclosure Statement

Post of executive /consultant： AB Pharma Co.,

Faculty Disclosure Off-Label Product Use

We have no conflict of interests related to

for Respiratory Care and Rehabilitation

Faculty Disclosure Off-Label Product Use

If yes, give company names.

COI Disclosure All authors Name : （◎ Corresponding author）

Japanese Society of Nephrology ＣＯＩ disclosure presenter： ○○○○,. ○○○○(

List disclosure information here.

Financial Disclosure Financial Interest / Affiliation

COI Disclosure of First Author

　*Please use this slide template when there is no

Japan Oncoplastic Breast Surgery Society

COI Disclosure of First Author

　Form1-A　There is no state of conflict of interest requiring disclosure

COI Disclosure For speakers with a COI to declare

Presentation transcript:

Japan Endovascular Treatment Conference 2014 JET2014 Digital Poster

Japan Endovascular Treatment Conference 2014Japan Endovascular Treatment Conference 20 COI Disclosure; Name, MD. For the 12 months preceding this CME activity, I disclose the following types of financial relationships: Honoraria received from: Consulted for: Held common stock in: Research, clinical trial, or drug study funds received from: I WILL or WILL NOT be discussing products that are investigational or not labeled for use under discussion.

Japan Endovascular Treatment Conference 2014Japan Endovascular Treatment Conference 20

Japan Endovascular Treatment Conference 2014

JET2014 Hilton Tokyo Hotel February 14(Fri)-16(Sun)2014